AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717,999 | -3.5% | 59,046 | -0.3% | 0.01% | 0.0% |
| Q2 2023 | $744,130 | +7.2% | 59,246 | -5.4% | 0.01% | 0.0% |
| Q1 2023 | $694,389 | -15.2% | 62,614 | -6.7% | 0.01% | -15.4% |
| Q4 2022 | $819,022 | +42.9% | 67,078 | +22.2% | 0.01% | +30.0% |
| Q3 2022 | $573,000 | -6.4% | 54,872 | -3.8% | 0.01% | 0.0% |
| Q2 2022 | $612,000 | +7.6% | 57,023 | -5.2% | 0.01% | +25.0% |
| Q1 2022 | $569,000 | -10.3% | 60,134 | +9.6% | 0.01% | 0.0% |
| Q4 2021 | $634,000 | +54.3% | 54,869 | +27.4% | 0.01% | +33.3% |
| Q3 2021 | $411,000 | -6.8% | 43,052 | -5.8% | 0.01% | 0.0% |
| Q2 2021 | $441,000 | -3.9% | 45,705 | -1.7% | 0.01% | -14.3% |
| Q1 2021 | $459,000 | – | 46,502 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |